
Dxone XP 250mg/31.25mg Injection
Marketer
Dr. D Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Dxone XP 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be overseen by a medical professional. Complete the prescribed course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption may exacerbate drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Prioritize rest, nutritious food, and ample hydration for optimal recovery. Monitoring via laboratory tests may be conducted to assess therapeutic response.
Uses of Dxone XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Dxone XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Dxone XP 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Dxone XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dxone XP 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Dxone XP 250mg/31.25mg) unites a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial proliferation. Tazobactam counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Dxone XP 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Dxone XP (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Dxone XP 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Dxone XP 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Dxone XP 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Dxone XP 250mg/31.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Dxone XP 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dxone XP 250mg/31.25mg Injection :
Omitting a scheduled dose of Dxone XP 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Dxone XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
